Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, Mercury Laboratories has informed that a meeting of the Board of Directors of the Company will be held on Tuesday, November 11, 2025 to consider and approve the Unaudited Financial Results for the quarter and half year ended on September 30, 2025. Further, as per the Company’s Code of Conduct for Prevention of Insider Trading, the company has informed that the ‘Trading Window’ has already been closed with effect from October 01, 2025 and shall continue to remain closed till 48 hours after the declaration of the unaudited financial results for the quarter and half year ended on September 30, 2025.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1654.70 |
| Dr. Reddys Lab | 1232.00 |
| Cipla | 1229.60 |
| Zydus Lifesciences | 915.45 |
| Lupin | 2332.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: